News
The Buckle, Inc. Reports June 2022 Net Sales
The Buckle, Inc. (NYSE: BKE) announced today that comparable store net sales, for stores open at least one year, for the 5-week period ended July 2, 2022 decreased 1.7 percent from comparable store
BitNile Holdings’ Subsidiary Ault Alliance Does Not Acquire EYP
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”) announced today that its subsidiary, Ault Alliance, Inc. (“Ault Alliance”), did not acquire
Chelverton UK Dividend Trust plc: Net Asset Value(s)
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter of 2022.
Press release date / time: Wednesday, July 27, shortly after 22:05
Sensirion Connected Solutions AG: Continuous methane emissions monitoring solution for the energy industry
Americans are Delaying Non-Emergency Medical Care in Higher Numbers than Last Year
A national survey conducted by Discover Personal Loans has found that financial stress is impacting how Americans seek and pay for medical care.
As Americans find themselves living through a
Coupon Rate of Subordinated Debt Securities to Qualified Investors
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Hardman & Co Research: Appreciate Group (APP) FY’22 results: going for growth
DGAP-Adhoc: tick Trading Software AG: Adjustment of the forecast for the financial year 2021/2022
DGAP-Adhoc: Varengold Bank AG: Half-year result 2022 well above plan
DGAP-News: BIKE24 expands its climate protection activities and has again been confirmed as a climate-neutral company
Lysogene Provides Additional Update on AAVance Phase 2/3 Gene Therapy Clinical Trial with LYS-SAF302 in children with MPS IIIA
Regulatory News:
Lysogene (Paris:LYS)(FR0013233475 – LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today communicates additional preliminary data
Fix Price announces the update on the Board of Directors
Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Ørsted awarded contract for world’s single biggest offshore wind farm
DGAP-News: IBU-tec advanced materials AG Concludes Agreements with International Raw Material Suppliers to Ensure Sustainable Materials Procurement
DGAP-News: SUSE S.A.: The Supervisory Board of SUSE S.A. nominates Sheng Liang to the Supervisory Board, replacing Matteo Thun
Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model
DGAP-News: SUSE S.A.: Q2 Results Demonstrate the Strength of SUSE’s Mission-Critical Subscription Business
DGAP-News: Northern Data reports on operations for June 2022